Pitolisant
Pitolisant is a pharmaceutical drug with 13 clinical trials. Currently 2 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
2
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
WAKIX® (Pitolisant) Pregnancy Registry
A Study of Pitolisant in Participants With Prader-Willi Syndrome
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents
Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Clinical Trials (13)
WAKIX® (Pitolisant) Pregnancy Registry
A Study of Pitolisant in Participants With Prader-Willi Syndrome
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents
Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA
Pitolisant in Refractory Restless Legs Syndrome
Insulin Tolerance Test Study in Patients With Type 1 Diabetes
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers
Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13